错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Efficacy of dual-task augmented reality rehabilitation in non-hospitalized adults with self-reported long COVID fatigue and cognitive impairment: a pilot study

  • Manuela Deodato,
  • Caterina Qualizza,
  • Miriam Martini,
  • Laura Mazzari,
  • Giovanni Furlanis,
  • Alex Buoite Stella,
  • Paolo Manganotti

摘要

Background

Cognitive impairment and chronic fatigue represent common characteristics of the long COVID syndrome. Different non-pharmacological treatments have been proposed, and physiotherapy has been proposed to improve the symptoms. This study aimed to evaluate the effects of a dual-task augmented reality rehabilitation protocol in people with long COVID fatigue and cognitive impairment.

Methods and materials

Ten non-hospitalized adults with reported fatigue and “brain fog” symptoms after COVID (7/10 females, 50 years, range 41–58) who participated in 20 sessions of a 1-h “dual-task” training, were compared to 10 long COVID individuals with similar demographics and symptoms (9/10 females, 56 years, range 43–65), who did not participate to any rehabilitation protocol. Cognitive performance was assessed with the Trail Making Test (TMT-A and -B) and Frontal Assessment Battery (FAB), and cardiovascular and muscular fatigue were assessed with the fatigue severity scale (FSS), six-minute walking test and handgrip endurance. Finally, transcranial magnetic stimulation (TMS) investigated cortical excitability.

Results

The mixed-factors analysis of variance found a significant interaction effect only in cognitive performance evaluation, suggesting TMT-B execution time decreased (− 15.9 s, 95% CI 7.6–24.1, P = 0.001) and FAB score improved (1.88, 95% CI 2.93–0.82, P = 0.002) only in the physiotherapy group. For the remaining outcomes, no interaction effect was found, and most parameters similarly improved in the two groups.

Conclusion

The preliminary results from this study suggest that dual-task rehabilitation could be a feasible protocol to support cognitive symptoms recovery after COVID-19 and could be helpful in those individuals suffering from persisting and invalidating symptoms.